John Laterra - Publications

Affiliations: 
Johns Hopkins University, Baltimore, MD 
Area:
Neuroscience Biology

78 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Xia S, Ma D, Liu S, Lal B, Wei S, Wang S, Zhan D, Zhang H, Lee RS, Gao P, Lopez-Bertoni H, Ying M, Li JJ, Laterra J, Wilson MA. Extracellular matrix protein tenascin C increases phagocytosis mediated by CD47 loss of function in glioblastoma. Cancer Research. PMID 30898840 DOI: 10.1158/0008-5472.CAN-18-3125  0.36
2019 Xu X, Xu J, Knutsson L, Liu J, Liu H, Li Y, Lal B, Laterra J, Artemov D, Liu G, van Zijl PCM, Chan KWY. The effect of the mTOR inhibitor rapamycin on glucoCEST signal in a preclinical model of glioblastoma. Magnetic Resonance in Medicine. PMID 30793789 DOI: 10.1002/mrm.27683  0.36
2018 Jiang S, Eberhart CG, Lim M, Heo HY, Zhang Y, Blair L, Wen Z, Holdhoff M, Lin D, Huang P, Qin H, Quiñones-Hinojosa A, Weingart J, Barker P, Pomper MG, ... Laterra J, et al. Identifying Recurrent Malignant Glioma after Treatment Using Amide Proton Transfer-Weighted MR Imaging: A Validation Study with Image-Guided Stereotactic Biopsy. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 30366937 DOI: 10.1158/1078-0432.CCR-18-1233  0.36
2018 Sehgal AA, Li Y, Lal B, Yadav NN, Xu X, Xu J, Laterra J, van Zijl PCM. CEST MRI of 3-O-methyl-D-glucose uptake and accumulation in brain tumors. Magnetic Resonance in Medicine. PMID 30206994 DOI: 10.1002/mrm.27489  0.36
2018 Lopez-Bertoni H, Kozielski K, Rui Y, Lal B, Vaughan H, Wilson D, Mihelson N, Eberhart C, Laterra J, Green JJ. Bioreducible polymeric nanoparticles containing multiplexed cancer stem cell-regulating miRNAs inhibit glioblastoma growth and prolong survival. Nano Letters. PMID 29927251 DOI: 10.1021/acs.nanolett.8b00390  0.36
2018 Oyinlade O, Wei S, Lal B, Laterra J, Zhu H, Goodwin CR, Wang S, Ma D, Wan J, Xia S. Targeting UDP-α-D-glucose 6-dehydrogenase inhibits glioblastoma growth and migration. Oncogene. PMID 29479058 DOI: 10.1038/s41388-018-0138-y  0.6
2017 Salas Fragomeni RA, Menke JR, Holdhoff M, Ferrigno C, Laterra JJ, Solnes LB, Javadi MS, Szabo Z, Pomper MG, Rowe SP. Prostate-Specific Membrane Antigen-Targeted Imaging With [18F]DCFPyL in High-Grade Gliomas. Clinical Nuclear Medicine. PMID 28737579 DOI: 10.1097/RLU.0000000000001769  0.36
2017 Jiang S, Eberhart CG, Zhang Y, Heo HY, Wen Z, Blair L, Qin H, Lim M, Quinones-Hinojosa A, Weingart JD, Barker PB, Pomper MG, Laterra J, van Zijl PCM, Blakeley JO, et al. Amide proton transfer-weighted magnetic resonance image-guided stereotactic biopsy in patients with newly diagnosed gliomas. European Journal of Cancer (Oxford, England : 1990). 83: 9-18. PMID 28704644 DOI: 10.1016/j.ejca.2017.06.009  0.36
2016 Goodwin CR, Woodard CL, Zhou X, Pan J, Olivi A, Xia S, Bettegowda C, Sciubba DM, Pevsner J, Zhu H, Laterra J. Microarray-Based Phospho-Proteomic Profiling of Complex Biological Systems. Translational Oncology. 9: 124-9. PMID 27084428 DOI: 10.1016/j.tranon.2016.02.001  0.36
2016 Tilghman J, Schiapparelli P, Lal B, Ying M, Quinones-Hinojosa A, Xia S, Laterra J. Regulation of Glioblastoma Tumor-Propagating Cells by the Integrin Partner Tetraspanin CD151. Neoplasia (New York, N.Y.). 18: 185-98. PMID 26992919 DOI: 10.1016/j.neo.2016.02.003  0.36
2016 Lesniak W, Oskolkov N, Song X, Lal B, Yang X, Pomper MG, Laterra J, Nimmagadda S, McMahon MT. Salicylic Acid Conjugated Dendrimers Are a Tunable, High Performance CEST MRI NanoPlatform. Nano Letters. PMID 26910126 DOI: 10.1021/acs.nanolett.5b04517  0.36
2016 Sun H, Luo L, Lal B, Ma X, Chen L, Hann CL, Fulton AM, Leahy DJ, Laterra J, Li M. A monoclonal antibody against KCNK9 K(+) channel extracellular domain inhibits tumour growth and metastasis. Nature Communications. 7: 10339. PMID 26842342 DOI: 10.1038/ncomms10339  0.36
2016 Goodwin CR, Liang L, Abu-Bonsrah N, Hdeib A, Elder BD, Kosztowski T, Bettegowda C, Laterra J, Burger P, Sciubba DM. Extraneural Glioblastoma Multiforme Vertebral Metastasis. World Neurosurgery. 89: 578-582.e3. PMID 26704201 DOI: 10.1016/j.wneu.2015.11.061  0.36
2015 Xu X, Chan KW, Knutsson L, Artemov D, Xu J, Liu G, Kato Y, Lal B, Laterra J, McMahon MT, van Zijl PC. Dynamic glucose enhanced (DGE) MRI for combined imaging of blood-brain barrier break down and increased blood volume in brain cancer. Magnetic Resonance in Medicine. PMID 26404120 DOI: 10.1002/mrm.25995  0.36
2015 Xia S, Lal B, Tung B, Wang S, Goodwin CR, Laterra J. Tumor microenvironment tenascin-C promotes glioblastoma invasion and negatively regulates tumor proliferation. Neuro-Oncology. PMID 26320116 DOI: 10.1093/neuonc/nov171  0.36
2015 Lee EJ, Rath P, Liu J, Ryu D, Pei L, Noonepalle SK, Shull AY, Feng Q, Litofsky NS, Miller DC, Anthony DC, Kirk MD, Laterra J, Deng L, Xin HB, et al. Identification of Global DNA Methylation Signatures in Glioblastoma-Derived Cancer Stem Cells. Journal of Genetics and Genomics = Yi Chuan Xue Bao. 42: 355-71. PMID 26233891 DOI: 10.1016/j.jgg.2015.06.003  0.36
2015 Song X, Xu J, Xia S, Yadav NN, Lal B, Laterra J, Bulte JW, van Zijl PC, McMahon MT. Multi-echo length and offset VARied saturation (MeLOVARS) method for improved CEST imaging. Magnetic Resonance in Medicine. 73: 488-96. PMID 25516490 DOI: 10.1002/mrm.25567  0.36
2014 Ying M, Tilghman J, Wei Y, Guerrero-Cazares H, Quinones-Hinojosa A, Ji H, Laterra J. Kruppel-like factor-9 (KLF9) inhibits glioblastoma stemness through global transcription repression and integrin α6 inhibition. The Journal of Biological Chemistry. 289: 32742-56. PMID 25288800 DOI: 10.1074/jbc.M114.588988  0.36
2014 Sagal J, Zhan X, Xu J, Tilghman J, Karuppagounder SS, Chen L, Dawson VL, Dawson TM, Laterra J, Ying M. Proneural transcription factor Atoh1 drives highly efficient differentiation of human pluripotent stem cells into dopaminergic neurons. Stem Cells Translational Medicine. 3: 888-98. PMID 24904172 DOI: 10.5966/sctm.2013-0213  0.36
2014 Sun P, Xia S, Lal B, Shi X, Yang KS, Watkins PA, Laterra J. Lipid metabolism enzyme ACSVL3 supports glioblastoma stem cell maintenance and tumorigenicity. Bmc Cancer. 14: 401. PMID 24893952 DOI: 10.1186/1471-2407-14-401  0.36
2014 Tilghman J, Wu H, Sang Y, Shi X, Guerrero-Cazares H, Quinones-Hinojosa A, Eberhart CG, Laterra J, Ying M. HMMR maintains the stemness and tumorigenicity of glioblastoma stem-like cells. Cancer Research. 74: 3168-79. PMID 24710409 DOI: 10.1158/0008-5472.CAN-13-2103  0.36
2014 Hong X, Liu L, Wang M, Ding K, Fan Y, Ma B, Lal B, Tyler B, Mangraviti A, Wang S, Wong J, Laterra J, Zhou J. Quantitative multiparametric MRI assessment of glioma response to radiotherapy in a rat model. Neuro-Oncology. 16: 856-67. PMID 24366911 DOI: 10.1093/neuonc/not245  0.36
2013 Woodard CL, Goodwin CR, Wan J, Xia S, Newman R, Hu J, Zhang J, Hayward SD, Qian J, Laterra J, Zhu H. Profiling the dynamics of a human phosphorylome reveals new components in HGF/c-Met signaling. Plos One. 8: e72671. PMID 24023761 DOI: 10.1371/journal.pone.0072671  0.36
2013 Rath P, Lal B, Ajala O, Li Y, Xia S, Kim J, Laterra J. In Vivo c-Met Pathway Inhibition Depletes Human Glioma Xenografts of Tumor-Propagating Stem-Like Cells. Translational Oncology. 6: 104-11. PMID 23556031  0.36
2013 Zhou J, Zhu H, Lim M, Blair L, Quinones-Hinojosa A, Messina SA, Eberhart CG, Pomper MG, Laterra J, Barker PB, van Zijl PC, Blakeley JO. Three-dimensional amide proton transfer MR imaging of gliomas: Initial experience and comparison with gadolinium enhancement. Journal of Magnetic Resonance Imaging : Jmri. 38: 1119-28. PMID 23440878 DOI: 10.1002/jmri.24067  0.36
2012 Zhang Y, Pullambhatla M, Laterra J, Pomper MG. Influence of bioluminescence imaging dynamics by D-luciferin uptake and efflux mechanisms. Molecular Imaging. 11: 499-506. PMID 23084250 DOI: 10.2310/7290.2012.00005  0.36
2012 Rosca EV, Lal B, Koskimaki JE, Popel AS, Laterra J. Collagen IV and CXC chemokine-derived antiangiogenic peptides suppress glioma xenograft growth. Anti-Cancer Drugs. 23: 706-12. PMID 22495619 DOI: 10.1097/CAD.0b013e3283531041  0.36
2012 Wang SD, Rath P, Lal B, Richard JP, Li Y, Goodwin CR, Laterra J, Xia S. EphB2 receptor controls proliferation/migration dichotomy of glioblastoma by interacting with focal adhesion kinase. Oncogene. 31: 5132-43. PMID 22310282 DOI: 10.1038/onc.2012.16  0.6
2012 Wang S, Chen Y, Lal B, Ford E, Tryggestad E, Armour M, Yan K, Laterra J, Zhou J. Evaluation of radiation necrosis and malignant glioma in rat models using diffusion tensor MR imaging. Journal of Neuro-Oncology. 107: 51-60. PMID 21948114 DOI: 10.1007/s11060-011-0719-x  0.36
2011 Goodwin CR, Lal B, Ho S, Woodard CL, Zhou X, Taeger A, Xia S, Laterra J. PTEN reconstitution alters glioma responses to c-Met pathway inhibition. Anti-Cancer Drugs. 22: 905-12. PMID 21654317 DOI: 10.1097/CAD.0b013e3283484750  0.6
2011 Li Y, Li A, Glas M, Lal B, Ying M, Sang Y, Xia S, Trageser D, Guerrero-Cázares H, Eberhart CG, Quiñones-Hinojosa A, Scheffler B, Laterra J. c-Met signaling induces a reprogramming network and supports the glioblastoma stem-like phenotype. Proceedings of the National Academy of Sciences of the United States of America. 108: 9951-6. PMID 21628563 DOI: 10.1073/pnas.1016912108  0.36
2011 Ying M, Wang S, Sang Y, Sun P, Lal B, Goodwin CR, Guerrero-Cazares H, Quinones-Hinojosa A, Laterra J, Xia S. Regulation of glioblastoma stem cells by retinoic acid: role for Notch pathway inhibition. Oncogene. 30: 3454-67. PMID 21383690 DOI: 10.1038/onc.2011.58  0.36
2011 Wen PY, Schiff D, Cloughesy TF, Raizer JJ, Laterra J, Smitt M, Wolf M, Oliner KS, Anderson A, Zhu M, Loh E, Reardon DA. A phase II study evaluating the efficacy and safety of AMG 102 (rilotumumab) in patients with recurrent glioblastoma. Neuro-Oncology. 13: 437-46. PMID 21297127 DOI: 10.1093/neuonc/noq198  0.36
2011 Ying M, Sang Y, Li Y, Guerrero-Cazares H, Quinones-Hinojosa A, Vescovi AL, Eberhart CG, Xia S, Laterra J. Krüppel-like family of transcription factor 9, a differentiation-associated transcription factor, suppresses Notch1 signaling and inhibits glioblastoma-initiating stem cells. Stem Cells (Dayton, Ohio). 29: 20-31. PMID 21280156 DOI: 10.1002/stem.561  0.36
2011 Zhou J, Tryggestad E, Wen Z, Lal B, Zhou T, Grossman R, Wang S, Yan K, Fu DX, Ford E, Tyler B, Blakeley J, Laterra J, van Zijl PC. Differentiation between glioma and radiation necrosis using molecular magnetic resonance imaging of endogenous proteins and peptides. Nature Medicine. 17: 130-4. PMID 21170048 DOI: 10.1038/nm.2268  0.36
2011 Bhang HE, Gabrielson KL, Laterra J, Fisher PB, Pomper MG. Tumor-specific imaging through progression elevated gene-3 promoter-driven gene expression. Nature Medicine. 17: 123-9. PMID 21151140 DOI: 10.1038/nm.2269  0.36
2010 Goodwin CR, Laterra J. Neuro-oncology: unmasking the multiforme in glioblastoma. Nature Reviews. Neurology. 6: 304-5. PMID 20531430 DOI: 10.1038/nrneurol.2010.67  0.6
2010 Jansen T, Tyler B, Mankowski JL, Recinos VR, Pradilla G, Legnani F, Laterra J, Olivi A. FasL gene knock-down therapy enhances the antiglioma immune response. Neuro-Oncology. 12: 482-9. PMID 20406899 DOI: 10.1093/neuonc/nop052  0.36
2010 Goodwin CR, Lal B, Zhou X, Ho S, Xia S, Taeger A, Murray J, Laterra J. Cyr61 mediates hepatocyte growth factor-dependent tumor cell growth, migration, and Akt activation. Cancer Research. 70: 2932-41. PMID 20233866 DOI: 10.1158/0008-5472.CAN-09-3570  0.6
2010 Fan S, Meng Q, Laterra JJ, Rosen EM. Scatter factor protects tumor cells against apoptosis caused by TRAIL. Anti-Cancer Drugs. 21: 10-24. PMID 19823077 DOI: 10.1097/CAD.0b013e32832afc3b  0.36
2009 Pei Z, Sun P, Huang P, Lal B, Laterra J, Watkins PA. Acyl-CoA synthetase VL3 knockdown inhibits human glioma cell proliferation and tumorigenicity. Cancer Research. 69: 9175-82. PMID 19920185 DOI: 10.1158/0008-5472.CAN-08-4689  0.36
2009 Rudin CM, Hann CL, Laterra J, Yauch RL, Callahan CA, Fu L, Holcomb T, Stinson J, Gould SE, Coleman B, LoRusso PM, Von Hoff DD, de Sauvage FJ, Low JA. Treatment of medulloblastoma with hedgehog pathway inhibitor GDC-0449. The New England Journal of Medicine. 361: 1173-8. PMID 19726761 DOI: 10.1056/NEJMoa0902903  0.36
2009 Li Y, Rory Goodwin C, Sang Y, Rosen EM, Laterra J, Xia S. Camptothecin and Fas receptor agonists synergistically induce medulloblastoma cell death: ROS-dependent mechanisms. Anti-Cancer Drugs. 20: 770-8. PMID 19633536 DOI: 10.1097/CAD.0b013e32832fe472  0.36
2009 Lal B, Goodwin CR, Sang Y, Foss CA, Cornet K, Muzamil S, Pomper MG, Kim J, Laterra J. EGFRvIII and c-Met pathway inhibitors synergize against PTEN-null/EGFRvIII+ glioblastoma xenografts. Molecular Cancer Therapeutics. 8: 1751-60. PMID 19584231 DOI: 10.1158/1535-7163.MCT-09-0188  0.36
2009 Zhang Y, Byun Y, Ren YR, Liu JO, Laterra J, Pomper MG. Identification of inhibitors of ABCG2 by a bioluminescence imaging-based high-throughput assay Cancer Research. 69: 5867-5875. PMID 19567678 DOI: 10.1158/0008-5472.CAN-08-4866  0.36
2009 Sun P, Xia S, Lal B, Eberhart CG, Quinones-Hinojosa A, Maciaczyk J, Matsui W, Dimeco F, Piccirillo SM, Vescovi AL, Laterra J. DNER, an epigenetically modulated gene, regulates glioblastoma-derived neurosphere cell differentiation and tumor propagation. Stem Cells (Dayton, Ohio). 27: 1473-86. PMID 19544453 DOI: 10.1002/stem.89  0.36
2009 Zhang Y, Laterra J, Pomper MG. Hedgehog pathway inhibitor HhAntag691 is a potent inhibitor of ABCG2/BCRP and ABCB1/Pgp. Neoplasia (New York, N.Y.). 11: 96-101. PMID 19107236 DOI: 10.1593/neo.81264  0.36
2009 Fan S, Meng Q, Laterra JJ, Rosen EM. Role of Src signal transduction pathways in scatter factor-mediated cellular protection. The Journal of Biological Chemistry. 284: 7561-77. PMID 19047046 DOI: 10.1074/jbc.M807497200  0.36
2009 McGirt MJ, Than KD, Weingart JD, Chaichana KL, Attenello FJ, Olivi A, Laterra J, Kleinberg LR, Grossman SA, Brem H, Quiñones-Hinojosa A. Gliadel (BCNU) wafer plus concomitant temozolomide therapy after primary resection of glioblastoma multiforme. Journal of Neurosurgery. 110: 583-8. PMID 19046047 DOI: 10.3171/2008.5.17557  0.36
2008 Li Y, Fan X, Goodwin CR, Laterra J, Xia S. Hepatocyte growth factor enhances death receptor-induced apoptosis by up-regulating DR5. Bmc Cancer. 8: 325. PMID 18992144 DOI: 10.1186/1471-2407-8-325  0.6
2008 Yi JM, Tsai HC, Glöckner SC, Lin S, Ohm JE, Easwaran H, James CD, Costello JF, Riggins G, Eberhart CG, Laterra J, Vescovi AL, Ahuja N, Herman JG, Schuebel KE, et al. Abnormal DNA methylation of CD133 in colorectal and glioblastoma tumors. Cancer Research. 68: 8094-103. PMID 18829568 DOI: 10.1158/0008-5472.CAN-07-6208  0.36
2008 Binning MJ, Niazi T, Pedone CA, Lal B, Eberhart CG, Kim KJ, Laterra J, Fults DW. Hepatocyte growth factor and sonic Hedgehog expression in cerebellar neural progenitor cells costimulate medulloblastoma initiation and growth. Cancer Research. 68: 7838-45. PMID 18829539 DOI: 10.1158/0008-5472.CAN-08-1899  0.36
2008 Zhou J, Blakeley JO, Hua J, Kim M, Laterra J, Pomper MG, van Zijl PC. Practical data acquisition method for human brain tumor amide proton transfer (APT) imaging. Magnetic Resonance in Medicine : Official Journal of the Society of Magnetic Resonance in Medicine / Society of Magnetic Resonance in Medicine. 60: 842-9. PMID 18816868 DOI: 10.1002/mrm.21712  0.36
2008 Li Y, Guessous F, Kwon S, Kumar M, Ibidapo O, Fuller L, Johnson E, Lal B, Hussaini I, Bao Y, Laterra J, Schiff D, Abounader R. PTEN has tumor-promoting properties in the setting of gain-of-function p53 mutations. Cancer Research. 68: 1723-31. PMID 18339852 DOI: 10.1158/0008-5472.CAN-07-1963  0.36
2008 Reznik TE, Sang Y, Ma Y, Abounader R, Rosen EM, Xia S, Laterra J. Transcription-dependent epidermal growth factor receptor activation by hepatocyte growth factor. Molecular Cancer Research : McR. 6: 139-50. PMID 18234969 DOI: 10.1158/1541-7786.MCR-07-0236  0.36
2008 Donahue MJ, Blakeley JO, Zhou J, Pomper MG, Laterra J, van Zijl PC. Evaluation of human brain tumor heterogeneity using multiple T1-based MRI signal weighting approaches. Magnetic Resonance in Medicine : Official Journal of the Society of Magnetic Resonance in Medicine / Society of Magnetic Resonance in Medicine. 59: 336-44. PMID 18183606 DOI: 10.1002/mrm.21467  0.36
2008 Li Y, Guessous F, Johnson EB, Eberhart CG, Li XN, Shu Q, Fan S, Lal B, Laterra J, Schiff D, Abounader R. Functional and molecular interactions between the HGF/c-Met pathway and c-Myc in large-cell medulloblastoma. Laboratory Investigation; a Journal of Technical Methods and Pathology. 88: 98-111. PMID 18059365 DOI: 10.1038/labinvest.3700702  0.36
2008 Salhotra A, Lal B, Laterra J, Sun PZ, van Zijl PC, Zhou J. Amide proton transfer imaging of 9L gliosarcoma and human glioblastoma xenografts. Nmr in Biomedicine. 21: 489-97. PMID 17924591 DOI: 10.1002/nbm.1216  0.36
2007 Zhang Y, Bressler JP, Neal J, Lal B, Bhang HE, Laterra J, Pomper MG. ABCG2/BCRP expression modulates D-Luciferin based bioluminescence imaging. Cancer Research. 67: 9389-97. PMID 17909048 DOI: 10.1158/0008-5472.CAN-07-0944  0.36
2007 Zhang J, van Zijl PC, Laterra J, Salhotra A, Lal B, Mori S, Zhou J. Unique patterns of diffusion directionality in rat brain tumors revealed by high-resolution diffusion tensor MRI. Magnetic Resonance in Medicine : Official Journal of the Society of Magnetic Resonance in Medicine / Society of Magnetic Resonance in Medicine. 58: 454-62. PMID 17763344 DOI: 10.1002/mrm.21371  0.36
2007 Xia S, Li Y, Rosen EM, Laterra J. Ribotoxic stress sensitizes glioblastoma cells to death receptor induced apoptosis: requirements for c-Jun NH2-terminal kinase and Bim. Molecular Cancer Research : McR. 5: 783-92. PMID 17699104 DOI: 10.1158/1541-7786.MCR-06-0433  0.36
2006 Ma Y, Yuan RQ, Fan S, Hu C, Goldberg ID, Laterra JJ, Rosen EM. Identification of genes that modulate sensitivity of U373MG glioblastoma cells to cis-platinum. Anti-Cancer Drugs. 17: 733-51. PMID 16926624 DOI: 10.1097/01.cad.0000217429.67455.18  0.36
2006 Xia S, Laterra J. Hepatocyte growth factor increases mitochondrial mass in glioblastoma cells. Biochemical and Biophysical Research Communications. 345: 1358-64. PMID 16730650 DOI: 10.1016/j.bbrc.2006.05.064  0.36
2006 Russell JC, Szuflita N, Khatri R, Laterra J, Hossain MA. Transgenic expression of human FGF-1 protects against hypoxic-ischemic injury in perinatal brain by intervening at caspase-XIAP signaling cascades. Neurobiology of Disease. 22: 677-90. PMID 16635575 DOI: 10.1016/j.nbd.2006.01.016  0.36
2006 Kim KJ, Wang L, Su YC, Gillespie GY, Salhotra A, Lal B, Laterra J. Systemic anti-hepatocyte growth factor monoclonal antibody therapy induces the regression of intracranial glioma xenografts. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 12: 1292-8. PMID 16489086 DOI: 10.1158/1078-0432.CCR-05-1793  0.36
2005 Li Y, Lal B, Kwon S, Fan X, Saldanha U, Reznik TE, Kuchner EB, Eberhart C, Laterra J, Abounader R. The scatter factor/hepatocyte growth factor: c-met pathway in human embryonal central nervous system tumor malignancy. Cancer Research. 65: 9355-62. PMID 16230398 DOI: 10.1158/0008-5472.CAN-05-1946  0.36
2005 Beckner ME, Gobbel GT, Abounader R, Burovic F, Agostino NR, Laterra J, Pollack IF. Glycolytic glioma cells with active glycogen synthase are sensitive to PTEN and inhibitors of PI3K and gluconeogenesis. Laboratory Investigation; a Journal of Technical Methods and Pathology. 85: 1457-70. PMID 16170333 DOI: 10.1038/labinvest.3700355  0.36
2005 Lal B, Xia S, Abounader R, Laterra J. Targeting the c-Met pathway potentiates glioblastoma responses to gamma-radiation. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 11: 4479-86. PMID 15958633 DOI: 10.1158/1078-0432.CCR-05-0166  0.36
2005 Xia S, Rosen EM, Laterra J. Sensitization of glioma cells to Fas-dependent apoptosis by chemotherapy-induced oxidative stress. Cancer Research. 65: 5248-55. PMID 15958570 DOI: 10.1158/0008-5472.CAN-04-4332  0.36
2005 Fan S, Gao M, Meng Q, Laterra JJ, Symons MH, Coniglio S, Pestell RG, Goldberg ID, Rosen EM. Role of NF-kappaB signaling in hepatocyte growth factor/scatter factor-mediated cell protection. Oncogene. 24: 1749-66. PMID 15688034 DOI: 10.1038/sj.onc.1208327  0.36
2004 Abounader R, Reznik T, Colantuoni C, Martinez-Murillo F, Rosen EM, Laterra J. Regulation of c-Met-dependent gene expression by PTEN. Oncogene. 23: 9173-82. PMID 15516982 DOI: 10.1038/sj.onc.1208146  0.36
2004 Madden SL, Cook BP, Nacht M, Weber WD, Callahan MR, Jiang Y, Dufault MR, Zhang X, Zhang W, Walter-Yohrling J, Rouleau C, Akmaev VR, Wang CJ, Cao X, St Martin TB, ... ... Laterra J, et al. Vascular gene expression in nonneoplastic and malignant brain. The American Journal of Pathology. 165: 601-8. PMID 15277233  0.36
2004 Hossain MA, Russell JC, Miknyoczki S, Ruggeri B, Lal B, Laterra J. Vascular endothelial growth factor mediates vasogenic edema in acute lead encephalopathy. Annals of Neurology. 55: 660-7. PMID 15122706 DOI: 10.1002/ana.20065  0.36
2004 Hossain MA, Russell JC, O'Brien R, Laterra J. Neuronal pentraxin 1: a novel mediator of hypoxic-ischemic injury in neonatal brain. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 24: 4187-96. PMID 15115814 DOI: 10.1523/JNEUROSCI.0347-04.2004  0.36
2004 Liang H, O'Reilly S, Liu Y, Abounader R, Laterra J, Maher VM, McCormick JJ. Sp1 regulates expression of MET, and ribozyme-induced down-regulation of MET in fibrosarcoma-derived human cells reduces or eliminates their tumorigenicity. International Journal of Oncology. 24: 1057-67. PMID 15067326  0.36
2004 Laterra JJ, Grossman SA, Carson KA, Lesser GJ, Hochberg FH, Gilbert MR. Suramin and radiotherapy in newly diagnosed glioblastoma: phase 2 NABTT CNS Consortium study. Neuro-Oncology. 6: 15-20. PMID 14769135 DOI: 10.1215/S1152851703000127  0.36
2003 Zhou J, Lal B, Wilson DA, Laterra J, van Zijl PC. Amide proton transfer (APT) contrast for imaging of brain tumors. Magnetic Resonance in Medicine : Official Journal of the Society of Magnetic Resonance in Medicine / Society of Magnetic Resonance in Medicine. 50: 1120-6. PMID 14648559 DOI: 10.1002/mrm.10651  0.36
2002 Abounader R, Lal B, Luddy C, Koe G, Davidson B, Rosen EM, Laterra J. In vivo targeting of SF/HGF and c-met expression via U1snRNA/ribozymes inhibits glioma growth and angiogenesis and promotes apoptosis. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 16: 108-10. PMID 11729097 DOI: 10.1096/fj.01-0421fje  0.36
Show low-probability matches.